
Results
374
Companies with a Future performance score of at least 3, ordered by Future performance score.
374 companies
Micro-X
Market Cap: AU$56.8m
Designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology.
MX1
AU$0.085
7D
-1.2%
1Y
-13.3%
Rox Resources
Market Cap: AU$405.7m
Engages in mineral exploration activities in Australia.
RXL
AU$0.43
7D
10.3%
1Y
152.9%
Adveritas
Market Cap: AU$124.8m
Provides funnel measurement, verification, and fraud prevention solutions for digital advertising in North America, Latin America, Asia Pacific, Australia, Europe, and internationally.
AV1
AU$0.14
7D
-10.0%
1Y
35.0%
Brightstar Resources
Market Cap: AU$260.7m
Engages in the exploration, development, and mining of gold properties in Australia.
BTR
AU$0.45
7D
-5.3%
1Y
-30.8%
Newfield Resources
Market Cap: AU$83.7m
Engages in the mine development, stope mining, and mineral exploration activities in Australia and Africa.
NWF
AU$0.089
7D
0%
1Y
-19.1%
Wisr
Market Cap: AU$58.1m
Engages in the lending business in Australia.
WZR
AU$0.034
7D
9.7%
1Y
17.2%
Vitasora Health
Market Cap: AU$43.5m
Researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.025
7D
4.2%
1Y
-66.7%
IRIS Metals
Market Cap: AU$55.7m
Engages in exploration, evaluation, and acquisition of mining tenements in South Dakota, the United States.
IR1
AU$0.23
7D
1.1%
1Y
-32.9%
Echo IQ
Market Cap: AU$152.8m
Engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia.
EIQ
AU$0.23
7D
-6.0%
1Y
-7.8%
Pointerra
Market Cap: AU$34.7m
Provides a cloud-based solution for storing, processing, managing, analyzing, extracting, visualizing, and sharing 3D data in Australia and the United States.
3DP
AU$0.043
7D
10.3%
1Y
0%
Titomic
Market Cap: AU$307.4m
Offers manufacturing and technology solutions for high-performance metal additive manufacturing in Australia, the United States, and Europe.
TTT
AU$0.20
7D
5.3%
1Y
0%
Catalyst Metals
Market Cap: AU$1.7b
Engages in the mineral exploration and evaluation in Australia.
CYL
AU$6.58
7D
-5.1%
1Y
141.9%
BlinkLab
Market Cap: AU$136.2m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$1.09
7D
24.7%
1Y
301.9%
St Barbara
Market Cap: AU$701.7m
Engages in the exploration, development, mining, and sale of gold.
SBM
AU$0.58
7D
1.8%
1Y
75.8%
Polymetals Resources
Market Cap: AU$302.6m
Engages in the exploration and development of gold projects in West Africa.
POL
AU$1.13
7D
22.2%
1Y
34.5%
Lunnon Metals
Market Cap: AU$70.4m
Focuses on the exploration and development of nickel and gold in Australia.
LM8
AU$0.32
7D
10.5%
1Y
21.2%
Pure Hydrogen
Market Cap: AU$31.4m
Engages in the development of zero emissions vehicles and natural gas energy projects in Australia and Botswana.
PH2
AU$0.081
7D
1.3%
1Y
-29.6%
Elsight
Market Cap: AU$418.2m
Provides connectivity solutions in Israel, the United States, and internationally.
ELS
AU$1.91
7D
10.4%
1Y
382.3%
Emerald Resources
Market Cap: AU$3.5b
Engages in the exploration and development of mineral reserves in Cambodia and Australia.
EMR
AU$5.28
7D
0.8%
1Y
46.7%
IperionX
Market Cap: AU$1.7b
Engages in the development of its mineral properties in the United States.
IPX
AU$4.92
7D
1.4%
1Y
7.9%
Capricorn Metals
Market Cap: AU$6.1b
Explores, develops, evaluates, and produces gold in Australia.
CMM
AU$14.19
7D
-0.5%
1Y
119.7%
Botanix Pharmaceuticals
Market Cap: AU$236.5m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.12
7D
4.3%
1Y
-64.7%
Horizon Minerals
Market Cap: AU$218.8m
Engages in the exploration, development, and production of gold and other mineral resources in Australia.
HRZ
AU$0.071
7D
-11.3%
1Y
77.5%
Lotus Resources
Market Cap: AU$434.6m
Engages in the exploration and development of uranium projects in Africa.
LOT
AU$0.16
7D
0%
1Y
-28.9%
EZZ Life Science Holdings
Market Cap: AU$76.4m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$1.62
7D
-29.9%
1Y
-37.5%
Alpha HPA
Market Cap: AU$824.5m
A specialty materials and technology company, focuses on the delivery and operation of the HPA First and Alpha Sapphire projects in Queensland.
A4N
AU$0.72
7D
-1.4%
1Y
-26.8%
Nova Eye Medical
Market Cap: AU$38.5m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.14
7D
0%
1Y
-12.9%
Income Asset Management Group
Market Cap: AU$26.1m
Provides financial product solutions in cash/deposits and fixed income in Australia.
IAM
AU$0.028
7D
-3.4%
1Y
0%
West African Resources
Market Cap: AU$3.2b
Engages in the mining, mineral processing, acquisition, exploration, and project development of gold projects in West Africa.
WAF
AU$2.82
7D
2.5%
1Y
86.8%
Stealth Group Holdings
Market Cap: AU$180.2m
Operates as an industrial distribution company in Australia and internationally.
SGI
AU$1.21
7D
1.3%
1Y
164.8%
Wrkr
Market Cap: AU$237.0m
Provides software as a service to solve compliance needs for companies to process pay, superannuation and SMSF contributions, onboard new staff and contractors, and check credentials of new employees and contractors in Australia.
WRK
AU$0.13
7D
2.0%
1Y
104.9%
ImpediMed
Market Cap: AU$72.3m
A medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally.
IPD
AU$0.035
7D
-4.1%
1Y
-31.7%
Harmoney
Market Cap: AU$78.8m
Provides secured and unsecured personal loans through online in Australia and New Zealand.
HMY
AU$0.76
7D
-6.7%
1Y
111.1%
Meeka Metals
Market Cap: AU$716.0m
Engages in the exploration and development of gold properties in Western Australia.
MEK
AU$0.24
7D
0%
1Y
210.1%
Biome Australia
Market Cap: AU$87.1m
Engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally.
BIO
AU$0.40
7D
-1.3%
1Y
-29.5%
Mesoblast
Market Cap: AU$3.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.52
7D
-7.4%
1Y
43.2%